Impact of Single-Nucleotide Polymorphisms of CTLA-4, CD80 and CD86 on the Effectiveness of Abatacept in Patients with Rheumatoid Arthritis

Pete, NM; Montoro, MDM; Ramirez, CP; Martin, AS; de la Plata, JEM; Martinez, FM; Caliz, RC; Daddaoua, A; Tortosa, MDR; Morales, AJ

Ramirez, CP (corresponding author), Univ Hosp Virgen Macarena, Pharmacogenet Unit, Pharm Serv, Dr Fedriani 3, Seville 41009, Spain.

JOURNAL OF PERSONALIZED MEDICINE, 2020; 10 (4):

Abstract

Abatacept (ABA) is used as a first-line treatment in patients diagnosed with moderate and severe rheumatoid arthritis (RA). The interindividual respon......

Full Text Link